3SBio Inc., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in China (CN) and operates extensively across major regions in Asia. Founded in 1993, the company has achieved significant milestones, establishing itself as a leader in the development and production of biopharmaceuticals.
Specialising in innovative therapies, 3SBio focuses on areas such as oncology, nephrology, and autoimmune diseases. Its core products, including recombinant proteins and monoclonal antibodies, are distinguished by their high quality and efficacy, catering to the evolving needs of healthcare providers and patients alike. With a strong market position, 3SBio has garnered recognition for its commitment to research and development, contributing to advancements in the biopharmaceutical landscape.
-19 vs industry average
3sbio’s score of 20 is lower than 28% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at 3sbio?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
3sbio's reported carbon emissions
3sbio, a pharmaceutical preparation manufacturing company headquartered in China, has reported its carbon emissions for the years 2019 through 2024.
In 2024, 3sbio's total Scope 1 and Scope 2 emissions were approximately 69,136,120 kg CO2e (market-based). Scope 1 emissions for 2024 were about 13,304,070 kg CO2e, and Scope 2 emissions were approximately 55,832,050 kg CO2e (market-based).
The company's total Scope 1 and Scope 2 emissions for 2023 were approximately 60,649,530 kg CO2e (location-based). This comprised around 11,663,450 kg CO2e of Scope 1 emissions and approximately 48,986,080 kg CO2e of Scope 2 emissions (location-based).
For 2022, 3sbio reported total Scope 1 and Scope 2 emissions of approximately 45,896,560 kg CO2e (location-based). This included roughly 7,257,230 kg CO2e of Scope 1 emissions and about 38,639,330 kg CO2e of Scope 2 emissions (location-based).
In 2021, total Scope 1 and 2 emissions were approximately 56,212,570 kg CO2e, with Scope 1 emissions around 6,587,770 kg CO2e and Scope 2 emissions at approximately 49,624,790 kg CO2e.
Previously, in 2020, total Scope 1 and 2 emissions amounted to roughly 47,720,880 kg CO2e, consisting of approximately 6,516,090 kg CO2e from Scope 1 and about 41,204,790 kg CO2e from Scope 2.
In 2019, total Scope 1 and 2 emissions were approximately 48,685,270 kg CO2e, with Scope 1 emissions at about 5,960,680 kg CO2e and Scope 2 emissions at approximately 42,724,590 kg CO2e.
3sbio has not disclosed Scope 3 emissions data for any of the reported years. The company does not currently have publicly documented reduction targets or commitments, such as through SBTi or Climate Pledge initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
3sbio’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for 3sbio yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
3sbio
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project